venBio Global Strategic Fund II L.P.'s Net Worth

$383 Million

Estimate Recalculated Feb 16, 2024 06:26PM EST

Who is venBio Global Strategic Fund II L.P.?

venBio Global Strategic Fund II L.P. has an estimated net worth of $383 Million. This is based on reported shares across multiple companies, which include Checkmate Pharmaceuticals, Inc., ALX ONCOLOGY HOLDINGS INC, Akero Therapeutics, Inc., Apellis Pharmaceuticals, Inc., Menlo Therapeutics Inc., and IMPEL NEUROPHARMA INC.

SEC CIK

venBio Global Strategic Fund II L.P.'s CIK is 0001634632

Past Insider Trading and Trends

2020 was venBio Global Strategic Fund II L.P.'s most active year for acquiring shares with 7 total transactions. venBio Global Strategic Fund II L.P.'s most active month to acquire stocks was the month of June. 2020 was venBio Global Strategic Fund II L.P.'s most active year for disposing of shares, totalling 32 transactions. venBio Global Strategic Fund II L.P.'s most active month to dispose stocks was the month of March. 2020 saw venBio Global Strategic Fund II L.P. paying a total of $19,207,000.00 for 11,646,518 shares, this is the most they've acquired in one year. In 2020 venBio Global Strategic Fund II L.P. cashed out on 32,925,100 shares for a total of $20,743,395.94, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Checkmate Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-5.75%
-131.65K
$10.45
-$1,375,564.42
2.16M
May 13 - May 16
Form 4
-6.57%
-160.90K
$10.39
-$1,671,823.84
2.29M
May 10 - May 12
Form 4
-3.42%
-86.68K
$10.37
-$898,920.56
2.45M
May 5 - May 9
Form 4
-9.65%
-270.68K
$10.38
-$2,809,332.35
2.54M
May 2 - May 4
Form 4
-6.34%
-190.03K
$10.38
-$1,972,578.78
2.81M
Apr 27 - Apr 29
Form 4
-4.15%
-129.78K
$10.39
-$1,347,796.50
3M
Apr 22 - Apr 26
Form 4
-14.91%
-547.73K
$10.41
-$5,700,491.17
3.13M
Apr 19 - Apr 21
Form 4
3.67M
$15.00
3.67M
Aug 11
Form 3
0
0
No matching records found

Akero Therapeutics, Inc. (AKRO) Snapshot price: $17.68

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.70%
-116.47K
$34.40
-$4,006,536.85
3.03M
Jul 1 - Jul 6
Form 4
-1.44%
-45.95K
$23.76
-$1,091,607.66
3.15M
Mar 4 - Mar 6
Form 4
-0.68%
-21.80K
$22.63
-$493,310.23
3.2M
Feb 28 - Mar 3
Form 4
-0.18%
-5.90K
$22.80
-$134,635.10
3.23M
Feb 25 - Feb 27
Form 4
-0.15%
-10.03K
$27.07
-$271,399.19
6.46M
Feb 10 - Feb 12
Form 4
-0.19%
-6.10K
$27.03
-$164,954.76
3.23M
Feb 6
Form 4
-2.48%
-82.34K
$25.77
-$2,121,726.32
3.24M
Feb 4 - Feb 5
Form 4
-12.95%
-494.00K
$20.23
-$9,993,620.00
3.32M
Jan 13
Form 4
-0.41%
-15.68K
$19.86
-$311,354.63
3.82M
Jan 8
Form 4
-1.88%
-73.22K
$19.86
-$1,454,529.98
3.83M
Jan 6 - Jan 7
Form 4
-0.90%
-35.50K
$19.71
-$699,721.20
3.91M
Jan 2 - Jan 3
Form 4
-0.36%
-14.32K
$23.96
-$343,258.90
3.94M
Dec 31
Form 4
3.95M
$16.00
3.95M
Jun 24
Form 3
0
0
No matching records found

IMPEL NEUROPHARMA INC (IMPL) Snapshot price: $0.05

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.76M
$15.00
2.76M
Apr 27
Form 4
0
0
Apr 22
Form 3
0
0
No matching records found

ALX ONCOLOGY HOLDINGS INC (ALXO) Snapshot price: $15.05

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+584.38%
7.97M
$19.00
9.34M
Jul 16 - Jul 21
Form 3
0
0
No matching records found

Apellis Pharmaceuticals, Inc. (APLS) Snapshot price: $68

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.58M
$14.00
3.58M
Nov 13
Form 3
0
0
No matching records found